Revelation Biosciences (REVB) Accumulated Expenses (2020 - 2026)
Revelation Biosciences (REVB) recorded Accumulated Expenses of $759,937 in Q2 2026, up 2.7% from $739,626 a year earlier and up 62.4% from the prior quarter.
Powered by 
Analysis
Revelation Biosciences (REVB) Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, Revelation Biosciences reported Accumulated Expenses of $1.4 million, up 23.7% from FY2024.
- Annual Accumulated Expenses has a five-year compound annual growth rate of 110.6% (FY2020 to FY2025).
- Across earlier years, Accumulated Expenses came in at $1.13 million in FY2024 (-1.9%), $1.15 million in FY2023 (+16.9%), $985,497 in FY2022 (-35.5%) and $1.53 million in FY2021.
- Quarterly Accumulated Expenses has ranged from $463,632 in Q1 2025 to $8.45 million in Q2 2024 over the past five years.
- On a year-over-year basis, Accumulated Expenses has increased for three consecutive quarters, with an average decline of 14.0% over the last eight quarters.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 23.7% in Q4 2025, against a decline of 91.3% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $468,082 (Q1 2026), $1.4 million (Q4 2025) and $819,381 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Revelation Biosciences | 3.20 Mn | -45.82 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 759,937.00 |
| Mar 31, 2026 | 468,082.00 |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 819,381.00 |
| Jun 30, 2025 | 739,626.00 |
| Mar 31, 2025 | 463,632.00 |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 934,372.00 |
| Jun 30, 2024 | 8.45 Mn |
| Mar 31, 2024 | 620,280.00 |
| Dec 31, 2023 | 1.15 Mn |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 496,870.00 |
| Mar 31, 2023 | 973,925.00 |
| Dec 31, 2022 | 985,497.00 |
| Sep 30, 2022 | 996,447.00 |
| Jun 30, 2022 | 2.17 Mn |
| Mar 31, 2022 | 3.71 Mn |
| Dec 31, 2021 | 1.53 Mn |
| Dec 31, 2020 | 33,772.00 |
API Access
Revelation Biosciences Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();